Skip to main content

Alaunos Therapeutics, Inc S-3, filed Nov 13, 2026

Alaunos Therapeutics, Inc. (TCRT)

Alaunos Therapeutics, Inc. registered up to 382,090,789 shares for resale by selling stockholders and will receive no proceeds. The registration follows the Velaris Therapeutics, Inc. acquisition closed October 13, 2026 and private placement closed October 14, 2026. AI summary

S-3 2026-11-13
View Original
Added on November 13, 2026